First Wave BioPharma Inc. (FWBI) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
777 YAMATO ROAD BOCA RATON, FL 33431 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 6/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 3,711,770 | 1,362,910 | 8,248,684 | 6,062,141 | 175,796 | 1,114,343 | |||
| Cash and cash equivalents | 3,711,770 | 1,362,910 | 8,248,684 | 6,062,141 | 175,796 | 1,114,343 | |||
| Restricted cash and investments | |||||||||
| Receivables | 93,014 | 551,489 | 2,637,303 | 3,172,676 | |||||
| Prepaid expense | 1,244,466 | 1,956,831 | 1,176,268 | 1,256,154 | 595,187 | 512,982 | |||
| Disposal group, including discontinued operation | |||||||||
| Other undisclosed current assets | |||||||||
| Total current assets: | 4,956,236 | 3,412,755 | 9,424,952 | 7,869,784 | 3,408,286 | 4,800,001 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 195,440 | 259,261 | 74,238 | 82,386 | ✕ | ||||
| Property, plant and equipment | 14,565 | 43,839 | 73,110 | 18,329 | 77,391 | 128,854 | |||
| Intangible assets, net (including goodwill) | 1,684,182 | 1,684,182 | 4,933,584 | 5,293,770 | 1,924,830 | ||||
| Goodwill | 1,684,182 | 1,684,182 | 2,054,048 | 1,886,686 | 1,924,830 | ||||
| Intangible assets, net (excluding goodwill) | 2,879,536 | 3,407,084 | |||||||
| Deposits noncurrent assets | 11,250 | 18,149 | |||||||
| Other noncurrent assets | 2,291,914 | ||||||||
| Other undisclosed noncurrent assets | 21,522 | 21,513 | 27,920 | 41,047 | 615,710 | ||||
| Total noncurrent assets: | 1,926,959 | 2,026,944 | 2,365,024 | 5,054,071 | 5,494,594 | 2,669,394 | |||
| TOTAL ASSETS: | 6,883,195 | 5,439,699 | 11,789,976 | 12,923,855 | 8,902,880 | 7,469,395 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 1,379,567 | 1,040,216 | 3,100,984 | 1,685,603 | 1,754,682 | 2,070,396 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | 112,543 | |||||
| Employee-related liabilities | ✕ | ✕ | ✕ | 253,225 | |||||
| Accounts payable | 554,277 | 720,040 | 2,681,914 | 1,685,603 | 1,754,682 | 2,070,396 | |||
| Accrued liabilities | 825,290 | 320,176 | 419,070 | 127,012 | 71,177 | 285,061 | |||
| Other undisclosed accounts payable and accrued liabilities | (127,012) | (183,720) | (538,286) | ||||||
| Debt | 612,784 | 603,494 | 641,236 | 552,405 | 1,521,302 | 255,032 | |||
| Disposal group, including discontinued operation | |||||||||
| Other liabilities | 4,239 | 12,138 | 8,092,807 | 57,417 | 476,224 | ||||
| Due to related parties | ✕ | ✕ | 533,428 | 670,095 | |||||
| Other undisclosed current liabilities | 1,136,727 | 827,639 | 465,361 | 13,250,000 | |||||
| Total current liabilities: | 3,133,317 | 2,483,487 | 12,300,388 | 15,545,425 | 4,285,636 | 2,995,523 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 146,949 | 214,060 | 7,311,138 | 19,123 | |||||
| Other liabilities | 7,311,138 | 19,123 | |||||||
| Operating lease, liability | 146,949 | 214,060 | ✕ | ||||||
| Total noncurrent liabilities: | 146,949 | 214,060 | 7,311,138 | 19,123 | |||||
| Total liabilities: | 3,280,266 | 2,697,547 | 19,611,526 | 15,564,548 | 4,285,636 | 2,995,523 | |||
| Temporary equity, carrying amount | |||||||||
| Equity | |||||||||
| Equity, attributable to parent | 3,602,929 | 2,742,152 | (7,821,550) | (2,640,693) | 4,617,244 | 4,473,872 | |||
| Common stock | 156 | 100 | 1,485 | 3,115 | 2,680 | 1,771 | |||
| Additional paid in capital | 187,931,445 | 171,275,741 | 147,305,147 | 93,834,936 | 68,575,851 | 53,139,259 | |||
| Accumulated other comprehensive loss | (1,224,135) | (1,112,546) | (1,266,555) | (1,150,112) | |||||
| Accumulated deficit | (184,328,672) | (168,533,689) | (153,904,047) | (95,366,198) | (62,694,732) | (47,517,046) | |||
| Total equity: | 3,602,929 | 2,742,152 | (7,821,550) | (2,640,693) | 4,617,244 | 4,473,872 | |||
| TOTAL LIABILITIES AND EQUITY: | 6,883,195 | 5,439,699 | 11,789,976 | 12,923,855 | 8,902,880 | 7,469,395 | |||
Income Statement (P&L) (USD)
| 6/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues (Net Investment Income) | 484 | |||||||
| Gross profit: | 484 | |||||||
| Operating expenses | (15,770,827) | (12,678,066) | (59,056,888) | (26,432,768) | (14,743,747) | (13,221,771) | ||
| Other operating expense, net (Other Expenses) | (433,939) | |||||||
| Other undisclosed operating loss | (484) | (210,000) | ||||||
| Operating loss: | (15,770,827) | (12,678,066) | (59,056,888) | (26,432,768) | (15,177,686) | (13,431,771) | ||
| Nonoperating income (expense) | (24,156) | (1,951,576) | 519,039 | |||||
| Other nonoperating expense | (4,224) | (232,741) | (3,252) | |||||
| Interest and debt expense | (22,463) | (15,879) | (11,235) | (609,998) | (433,939) | (101,846) | ||
| Loss from continuing operations before equity method investments, income taxes: | (15,817,446) | (14,645,521) | (58,549,084) | (27,042,766) | (15,611,625) | (13,533,617) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (5,628,700) | |||||||
| Loss from continuing operations before income taxes: | (15,817,446) | (14,645,521) | (58,549,084) | (32,671,466) | (15,611,625) | (13,533,617) | ||
| Income tax benefit | ||||||||
| Loss from continuing operations: | (15,817,446) | (14,645,521) | (58,549,084) | (32,671,466) | (15,611,625) | (13,533,617) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (58,549,084) | (32,671,466) | (15,611,625) | (13,533,617) | |
| Net loss: | (15,817,446) | (14,645,521) | (58,549,084) | (32,671,466) | (15,611,625) | (13,533,617) | ||
| Other undisclosed net income (loss) attributable to parent | 22,463 | 15,879 | 11,235 | 433,939 | ||||
| Net loss attributable to parent: | (15,794,983) | (14,629,642) | (58,537,849) | (32,671,466) | (15,177,686) | (13,533,617) | ||
| Preferred stock dividends and other adjustments | (308,128) | (296,127) | (465,361) | 905,660 | ||||
| Other undisclosed net loss available to common stockholders, basic | (47,300) | (25,515,378) | (9,966,532) | |||||
| Net loss available to common stockholders, basic: | (16,103,111) | (14,973,069) | (84,518,588) | (41,732,338) | (15,177,686) | (13,533,617) | ||
| Other undisclosed net income available to common stockholders, diluted | ||||||||
| Net loss available to common stockholders, diluted: | (16,103,111) | (14,973,069) | (84,518,588) | (41,732,338) | (15,177,686) | (13,533,617) | ||
Comprehensive Income (USD)
| 6/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (15,817,446) | (14,645,521) | (58,549,084) | (32,671,466) | (15,611,625) | (13,533,617) | ||
| Comprehensive loss: | (15,817,446) | (14,645,521) | (58,549,084) | (32,671,466) | (15,611,625) | (13,533,617) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 22,463 | 1,240,014 | (100,354) | (154,009) | 317,496 | (194,397) | ||
| Comprehensive loss, net of tax, attributable to parent: | (15,794,983) | (13,405,507) | (58,649,438) | (32,825,475) | (15,294,129) | (13,728,014) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.